ResMed | RMD - Interest Income

Stock Price
42.36
Daily Change
0.44 1.04%
Monthly
-2.65%
Yearly
14.44%
Q3 Forecast
42.03

ResMed reported $59K in Interest Income for its fiscal quarter ending in June of 2021.



Financials
Stock Price USD
Assets USD 8.17B
Cash and Equivalent USD 1.21B
Cost of Sales USD 518.56M
Current Assets USD 3.51B
Current Liabilities USD 1.02B
Debt USD 851.81M
Dividend Yield USD 0.82
EBIT USD 456.57M
EBITDA USD 530.86M
Employees USD 8.16K
EPS Earnings Per Share USD 2.58
Equity Capital and Reserves USD 5.97B
Gross Profit on Sales USD 829.44M
Interest Expense on Debt USD 775K
Interest Income USD 59K
Loan Capital USD 658.39M
Market Capitalization USD 43.89B
Net Income USD 379.7M
Operating Expenses USD 891.42M
Operating Profit USD 456.57M
Ordinary Share Capital USD 146.39M
PE Price to Earnings USD 28.85
Pre-Tax Profit USD 458.05M
Sales Revenues USD 1.35B
Selling and Administration Expenses USD 265.12M
Stock USD 975.96M
Trade Creditors USD 278.16M
Trade Debtors USD 990.67M

Interest Income Change Date
Ansell USD 2.6M 800K Jun/2024
Cochlear AUD 7.4M 2.2M Dec/2024
CSL USD 18M 1000K Dec/2024
Integral Diagnostics AUD 482K 103K Jun/2024
Nanosonics AUD 2.89M 230K Dec/2024
ResMed USD 59K 4K Jun/2021
Telix Pharmaceuticals AUD 1.37M 354K Jun/2024